Page last updated: 2024-08-26

4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and anatabine

4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol has been researched along with anatabine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carmella, SG; Hatsukami, DK; Hecht, SS; Jensen, J; Kramarczuk, I; Le, C; Li, YS; Losey, L; Murphy, SE; Puumala, SS; Roe, MR; Zimmerman, CL1
Carmella, SG; Hatsukami, DK; Hecht, SS; Jensen, J; Le, C; Link, CA; Losey, L; Murphy, SE; Puumala, SS1

Trials

2 trial(s) available for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and anatabine

ArticleYear
Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen.
    Journal of the National Cancer Institute, 2004, Jan-21, Volume: 96, Issue:2

    Topics: Adult; Aged; Alkaloids; Biomarkers, Tumor; Carcinogens; Cotinine; Female; Glucuronates; Humans; Lung Neoplasms; Male; Middle Aged; Nitrosamines; Pyridines; Research Design; Smoking; Smoking Cessation; Treatment Outcome

2004
A comparison of urinary biomarkers of tobacco and carcinogen exposure in smokers.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2004, Volume: 13, Issue:10

    Topics: Adult; Alkaloids; Biomarkers; Carcinogens; Endpoint Determination; Environmental Exposure; Female; Ganglionic Stimulants; Humans; Male; Nicotine; Nitrosamines; Polycyclic Aromatic Hydrocarbons; Pyridines; Reproducibility of Results; Smoking; Smoking Cessation; Urinalysis

2004